Senti Biosciences Inc.

NASDAQ: SNTI · Real-Time Price · USD
1.55
0.02 (1.31%)
At close: Aug 15, 2025, 3:59 PM
1.50
-3.19%
After-hours: Aug 15, 2025, 07:51 PM EDT

Senti Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 2.56M 4.29M 2.29M
Cost of Revenue
n/a 5.24M 3.92M 3.01M
Gross Profit
n/a -2.68M 366K -719K
Operating Income
-61.04M -92.73M -70.63M -40.45M
Interest Income
n/a 2.86M 1.7M 11K
Pretax Income
-52.79M -83.41M -58.21M -55.32M
Net Income
-52.79M -92.92M -58.21M -55.32M
Selling & General & Admin
26.37M 34.87M 40.85M 21.25M
Research & Development
34.36M 32.15M 34.07M 21.96M
Other Expenses
313K 27.69M 12.42M -470K
Operating Expenses
61.04M 95.29M 74.92M 42.74M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 94.7M 74.92M 42.74M
Income Tax Expense
n/a n/a -12.42M 11K
Shares Outstanding (Basic)
4.6M 4.44M 4.39M 4.37M
Shares Outstanding (Diluted)
4.6M 4.44M 4.39M 4.37M
EPS (Basic)
-11.49 -20.94 -13.25 -12.67
EPS (Diluted)
-11.49 -20.94 -13.25 -12.67
EBITDA
-46.94M -61.34M -70.63M -39.68M
EBIT
-52.79M -66.77M -62.08M -40.45M
Depreciation & Amortization
5.85M 5.43M 3.89M 3.01M